- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: DS-8273a nivolumab
Total 1897 results
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Cutaneous Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Mucosal Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
University of MelbourneThe AlfredRecruitingHIV I InfectionSingapore, Australia
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
Centre Leon BerardRecruiting
-
Persephone BiosciencesPharm-Olam InternationalRecruitingCarcinoma, Non-Small-Cell Lung | Carcinoma, ColorectalUnited States
-
Asan Medical CenterRecruitingHepatocellular Carcinoma | Biliary Tract CancerKorea, Republic of
-
Jason J. Luke, MDBristol-Myers Squibb; Agios Pharmaceuticals, Inc.CompletedGlioma | Advanced Solid Tumor | IDH1 MutationUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedMalignant Pleural MesotheliomaNetherlands
-
ImmuneSensor Therapeutics Inc.RecruitingOligoprogressiveUnited States
-
ExelixisRecruitingRenal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Metastatic Castration-resistant Prostate CancerUnited States, Poland, Spain, Switzerland, Austria, Australia, Belgium, Israel, Italy, New Zealand, France, Germany, United Kingdom
-
The Netherlands Cancer InstituteCompletedHead and Neck Neoplasms | ImmunotherapyNetherlands
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Immunocore LtdRecruitingAdvanced MelanomaUnited States, Australia
-
Bristol-Myers SquibbTerminatedCancer, HepatocellularChina, United States, Germany, Australia, Italy, Austria, Belgium, Czechia, France, Hong Kong, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Taiwan, Canada
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Mexico, Italy, Argentina, Brazil, Chile, France, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Goethe UniversityActive, not recruitingMetastatic Renal Cell CarcinomaSpain, Netherlands, United Kingdom, France, Germany, Belgium, Czechia
-
Gritstone bio, Inc.Bristol-Myers SquibbCompletedColorectal Cancer | Non Small Cell Lung Cancer | Gastroesophageal Adenocarcinoma | Urothelial CarcinomaUnited States, Australia
-
Momotaro-Gene Inc.Baylor College of Medicine; Synteract, Inc.Active, not recruitingMalignant Pleural MesotheliomaUnited States
-
Kohei ShitaraOno Pharmaceutical Co. Ltd; Bayer Yakuhin, Ltd.CompletedAdvanced and Metastatic Solid TumorJapan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Forschungsinstitut der Diabetes Akademie MergentheimHeinrich-Heine University, Duesseldorf; University of Giessen; German Diabetes...CompletedDiabetes Mellitus | Depressive SymptomsGermany
-
Ralph G ZinnerBristol-Myers SquibbRecruitingLung Cancer, Nonsmall Cell | Lung Cancer Stage IIIUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingNeoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NESCIO)Renal Cell CarcinomaUnited Kingdom, Netherlands
-
Gregory DanielsRecruitingMelanoma Stage Iv | Renal Cell Carcinoma, MetastaticUnited States
-
Immatics US, Inc.RecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerUnited States, Germany
-
AIO-Studien-gGmbHCompleted
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Australasian Gastro-Intestinal Trials GroupCompleted
-
Kyowa Kirin Co., Ltd.Ono Pharmaceutical Co. LtdCompleted
-
ImmuneSensor Therapeutics Inc.RecruitingOligometastatic DiseaseUnited States
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.CompletedNon-Small Cell Lung CancerUnited States, Spain, Japan, Netherlands, France
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Germany, Spain, Japan, Canada, France, Korea, Republic of, Italy, United Kingdom, China, Taiwan, Hungary, Singapore, Switzerland, Netherlands, Brazil, Mexico, Russian Federation, Puerto Rico, Poland, Hong Kong, Romania and more
-
AHS Cancer Control AlbertaAlberta Cancer FoundationUnknown
-
ARCAGY/ GINECO GROUPHoffmann-La RocheTerminated
-
Akamis BioBristol-Myers SquibbRecruitingMetastatic Cancer | Epithelial TumorUnited States, United Kingdom
-
Teclison Ltd.RecruitingHepatocellular Carcinoma | Gastric CancerUnited States
-
David Minor, MDUniversity of Chicago; Jefferson Medical College of Thomas Jefferson University and other collaboratorsActive, not recruitingUveal Melanoma | Hepatic MetastasesUnited States
-
Yonsei UniversityUnknownMelanomaKorea, Republic of
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbCompletedHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Head and Neck Cancer MetastaticUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin LymphomaUnited States
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
University of UtahBristol-Myers Squibb; Acrotech Biopharma Inc.Withdrawn
-
Dan ZandbergRecruitingMelanoma | Hepatocellular Carcinoma | NSCLC | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Urothelial Cancer | HNSCC | Microsatellite Instability-High Solid Malignant TumorUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Daiichi Sankyo, Inc.Completed
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Hallym University Medical CenterJeil Pharmaceutical Co., Ltd.Unknown